Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment

NCT06069843 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Depression
Mild Cognitive Impairment

Interventions

DRUG: IV Ketamine

Sponsor

Icahn School of Medicine at Mount Sinai